Clinical trial
Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy: A Pilot RCT
NCT03515356 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy: A Pilot RCT
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 13, 2018
- Completion date
- June 24, 2019
- Enrollment
- 54 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer, esophageal cancer, gastric cancer, gastrointestinal cancer, pancreatic cancer, stomach cancer